Foster City Newswire
Results 1 - 2 of 2 for "u:marketwatch.com" in Foster City, CA
Revenue for the Foster City, Calif.-based biotechnology company was $7.31 billion against last year's $3.12 billion, thanks mostly to sales of its Hepatitis C drug, Sovaldi. Gilead's adjusted earnings were $2.43 a share, 20 cents ahead of the $2.23 prediction from analysts polled by FactSet. Comment?
It's probably a foregone conclusion that anyone who has even heard of Gilead Sciences Inc. will be watching to see how the biotechnology company's sales of its hit hepatitis C drugs did when it reports fourth-quarter earnings after the close Tuesday. Thanks to its $1,000-a-day hit hepatitis C drug Sovaldi and an even pricier follow-on, Harvoni, Gilead's fourth-quarter net margin could exceed the 50% mark for the second time in three quarters. Comment?
- « Previous
- Next »
Copyright © 2015 Topix LLC